Compare Innovative Industrial Properties Inc (IIPR) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innovative Industrial Properties Inc vs Illumina, Inc. — how do they compare? Innovative Industrial Properties Inc trades at $63.9 (market cap $1.87B), while Illumina, Inc. trades at $192.8 (market cap $27.94B). The key difference: Illumina, Inc. is far larger — about 14.9× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays a 11.81% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| IIPR | ILMN | |
|---|---|---|
Market Cap | $1.87B | $27.94B |
Sector | Real Estate | Health |
52-Week High | $64.67 | $194.33 |
52-Week Low | $44.58 | $91.00 |
Enterprise Value | $2.25B | $29.33B |
Dividend Yield | 11.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IIPR trades at $63.25, down 1.89% today, with a bullish technical signal from moving averages. The REIT shows strong profitability with 88.46% gross margins and 45.58% net income margin, though revenue declined to $266M in 2025. Recent news highlights successful debt refinancing and upcoming Q2 2026 earnings on August 3rd, with analyst consensus leaning Hold (54.55%).
The outlook remains cautious due to revenue declines and mixed earnings performance, but strong margins and recent capital structure improvements provide stability. Key risks include cannabis sector volatility and tenant credit quality, while the 9% dividend yield offers income appeal. Wall Street sentiment is neutral with balanced risk-reward.
Illumina (ILMN) trades at $192.53, up 3.15% today, with bullish technical signals and strong fundamental recovery. The stock shows robust profitability with a 19.42% net margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and new executive appointments, reinforcing growth prospects in genomics.
Outlook remains positive driven by sequencing demand and cost control, but risks include competitive pressure from Roche's new sequencer and China market weakness. Analyst consensus is Buy with a $178 target, though the current price exceeds this, suggesting cautious optimism amid execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
